Renal cell carcinoma of end-stage renal disease: A histopathologic and molecular genetic study

被引:0
|
作者
Hughson, MD
Schmidt, L
Zbar, B
Daugherty, S
Meloni, AM
Silva, FG
Sandberg, AA
机构
[1] NCI, FREDERICK CANC RES & DEV CTR, BIOL CARCINOGENESIS & DEV PROGRAM, FREDERICK, MD 21701 USA
[2] NCI, FREDERICK CANC RES & DEV CTR, IMMUNOBIOL LAB, FREDERICK, MD 21701 USA
[3] SW BIOMED RES INST, SCOTTSDALE, AZ USA
[4] UNIV OKLAHOMA, HLTH SCI CTR, DEPT PATHOL, OKLAHOMA CITY, OK USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 11期
关键词
renal cell carcinoma; cancer genetics; ESRD;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal cell carcinomas (RCC) are responsible for the deaths of 3% to 4% of patients with ESRD. The clear cell carcinoma of the kidney, which comprises 80% of sporadic RCC within the general population, shows a deletion of gene sequences in the short arm of chromosome 3 (3p) in as many as 100% of cases. The von Hippel-Lindau tumor suppressor gene at 3p25-26 is found to be mutated in the nondeleted allele in 57% of these sporadic clear cell carcinomas. This study was undertaken to determine the histopathologic types of RCC occurring in ESRD patients in the United States and to investigate the frequency with which 3p genetic changes can be found in these ESRD tumors. Seventeen end-stage kidneys containing RCC were collected from 15 ESRD patients at ten US medical centers. The tumors were classified by Thoenes' histopathologic typing. DNA extracted from paraffin blocks of tumor and nontumorous tissue was analyzed by single-stranded conformational polymorphism analysis for von Hippel-Lindau mutations and by microsatellite amplification for deletion of 3p gene sequences. Twenty-one RCC were identified in the 18 kidneys, The 21 RCC were classified histopathologically as follows: clear cell, compact, three cases; chromophilic, tubulopapillary, 15 cases; chromophilic, compact, three cases. Among the three clear cell carcinomas, one showed 3p genetic loss, None of the chromophilic RCC showed a 3p deletion and none of 19 tumors studied by single-stranded conformational polymorphism analysis disclosed von Hippel-Lindau mutations. In contrast to the general population, clear cell RCC with 3p abnormalities represent only a small proportion of the renal carcinomas in this collection of ESRD tumors. The findings indicate that the genetic changes underlying the development of most ESRD tumors are different from those occurring in sporadic clear cell RCC and do not characteristically involve the inactivation of a 3p tumor suppressor gene.
引用
收藏
页码:2461 / 2468
页数:8
相关论文
共 50 条
  • [21] RENAL CELL CARCINOMA IN PATIENTS WITH END-STAGE RENAL DISEASE HAS FAVORABLE OVERALL PROGNOSIS
    Shrewsberry, Adam
    Osunkoya, Adeboye
    Jiang, Kun
    Westby, Ruth
    Canter, Daniel
    Pattaras, John
    Turgeon, Nicole
    Master, Viraj
    Ogan, Kenneth
    JOURNAL OF UROLOGY, 2013, 189 (04): : E303 - E303
  • [22] Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis
    Shrewsberry, Adam B.
    Osunkoya, Adeboye O.
    Jiang, Kun
    Westby, Ruth
    Canter, Daniel
    Pattaras, John
    Turgeon, Nicole
    Master, Viraj A.
    Ogan, Kenneth
    CLINICAL TRANSPLANTATION, 2014, 28 (02) : 211 - 216
  • [23] GENOMIC FEATURES OF RENAL CELL CARCINOMA DEVELOPED DURING END-STAGE RENAL DISEASE AND DIALYSIS
    Maekawa, Shigekatsu
    Johnson, Todd
    Fujita, Masashi
    Takata, Ryo
    Ikarashi, Daiki
    Matsuura, Tomohiko
    Kato, Renpei
    Kanehira, Mitsugu
    Sugimura, Jun
    Abe, Takaya
    Nakagawa, Hikewaki
    Obara, Wataru
    JOURNAL OF UROLOGY, 2023, 209 : E497 - E497
  • [24] Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis
    Maekawa, S.
    Johnson, T. A.
    Fujita, M.
    Takata, R.
    Ikarashi, D.
    Matsuura, T.
    Kato, R.
    Kanehira, M.
    Sugimura, J.
    Abe, T.
    Nakagawa, H.
    Obara, W.
    EUROPEAN UROLOGY, 2023, 83
  • [25] Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis
    Maekawa, Shigekatsu
    Fujita, Masahi
    Takata, Ryo
    Ikarashi, Daiki
    Matsuura, Tomohiko
    Kato, Renpei
    Kato, Yoichiro
    Kanehira, Mitsugu
    Sugimura, Jun
    Abe, Takaya
    Nakagawa, Hidewaki
    Obara, Wataru
    CANCER RESEARCH, 2023, 83 (07)
  • [26] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [27] Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: Cytogenetic and molecular genetic findings
    Hughson, MD
    Meloni, AM
    Silva, FG
    Sandberg, AA
    CANCER GENETICS AND CYTOGENETICS, 1996, 89 (01) : 65 - 68
  • [28] RENAL CELL CARCINOMA IN PATIENTS WITH END-STAGE RENAL DISEASE AND RENAL TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE
    Bayoud, Younes
    Menard, Johann
    Staerman, Frederic
    JOURNAL OF UROLOGY, 2010, 183 (04): : E483 - E483
  • [29] Renal transplantation in sickle cell disease patients with end-stage renal disease
    Abreo, K
    Zibari, G
    Sella, M
    Roggero, T
    McDonald, J
    TRANSPLANTATION, 1999, 67 (09) : S617 - S617
  • [30] Renal cell carcinoma associated with end stage renal disease
    Petrolla, AA
    MacLennan, GT
    JOURNAL OF UROLOGY, 2006, 176 (01): : 345 - 345